Change in Management at GME
Continuity, Experience and Fresh Impetus for the Future
(f.l.t.r.) Stefan Schulze, Virginie Cuadrado, Markus Krauss
German Medical Engineering GmbH (GME) is entering a new era following Stefan Schulze’s decision to step down from his role as Managing Director effective from 1 April. However, drawing on this many years of market and technology expertise, the former executive will remain closely associated with the company and will continue to support GME as Senior Consultant Business Development & New Markets.
In his capacity as company founder, Stefan Schulze has been instrumental in shaping and leading GME over a period spanning 15 years. Following the acquisition of the company by Thomas GmbH a year ago, he has determined that now is the appropriate moment to hand over management responsibilities and contribute to the next stage of development in a new role.
As his successor, Virginie Cuadrado will take up the position of Managing Director in the second quarter of the year, having been appointed with a view to shaping the next phase of GME’s growth. She brings with her extensive international experience in the healthcare industry and has held positions that include Sales, Business Development and Head of Global Product Management for companies such as Fresenius Medical Care, Fresenius Kabi and Sorin, today operating as LivaNova. She has formed an integral part of the Thomas team as Director Market and Product Management Healthcare since 2021 and also played a pivotal role in the acquisition of GME. Alongside her role in Post-Acquisition Integration Management, she assumed responsibility for Sales Management covering the Asia region in 2025.
The change at the helm of GME combines the benefits of continuity, experience and fresh impetus for the future.
Markus Krauss, CEO of Thomas, stated: “With Virginie Cuadrado at the helm and Stefan Schulze continuing in an advisory capacity, GME is well positioned to pursue its strategic direction and unlock new growth potential.”
GME has been part of the Thomas Group since April 2025. In acquiring the company, Thomas added Healthcare to its existing Mobility and Off-Highway segments – with a view to establishing a strong, complementary pillar for the future.

